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Both clinical as well as experimental data support the
concept of psoriasis being a T-cell-mediated immune
disease possibly triggered by bacterial superantigens.
Further analysis of its pathogenesis was facilitated by
the generation of a xenogeneic transplantation model
in which skin from psoriatic patients is grafted onto
SCID mice lacking functional B and T cells.
Applying this model it was demonstrated that psoria-
sis can be triggered by bacterial superantigens; this
process depends on the presence of immunocytes.
Mutated variants of the respective superantigens
exhibiting no measurable af®nity to HLA class II
molecules can function as competitive inhibitors
in vivo. Key words: animal model/autoimmunity/patho-
genesis/therapy. Journal of Investigative Dermatology
Symposium Proceedings 6:231±232, 2001
PSORIASIS AS AN ``INFECTIOUS DISEASE''
Although psoriasis is considered a T-cell-mediated (auto-)immune
disease, increasing evidence suggests an important role for bacteria
in its initiation. Exacerbation has been reported upon colonization
with Staphylococcus and Streptococcus, and especially acute guttate
psoriasis is frequently associated with bacterial infection. Moreover,
treatment with antibiotics is known to have a bene®cial effect in
psoriasis. Among the potential pathogenic factors triggering the
onset of psoriasis during an infection with gram-positive bacteria
are superantigens. These molecules are characterized by their ability
to activate T cells that share de®ned T cell receptor Vb-segments.
Superantigens are distinct with regard to the set of Vb-segments
they can interact with. The portion of the T cell repertoire
activated by any given superantigen lies in the range of 10%. Thus,
a pronounced shift in the Vb-repertoire of responding T cells is
expected to occur. Such a shift has indeed been reported by Leung
et al in acute guttate psoriasis (Leung et al, 1993), whereas the T cell
receptor repertoire in fully established plaque-stage psoriasis is more
in line with a conventional antigen present as prolonged T cell
stimulus (Prinz et al, 1999). To investigate the nature of the T cell
stimulus in psoriasis more directly, a suitable animal model was
needed.
A SCID-HU XENOGENEIC TRANSPLANTATION
MODEL FOR PSORIASIS
Animal models are widely used in basic and applied biomedical
research. Although complex by nature they often meet the criteria
of controlled manipulation of the parameters of interest. In this
regard the introduction of the knockout and transgenic technology
allowed the generation of animal models representing powerful
tools to de®ne the biologic role of genes, gene products, and cell
populations. This approach, however, has two shortcomings: (i)
frequently, manipulation of a single gene results in a highly
complex phenotype prompting more questions than the generation
of the respective animal answered; and (ii) by de®nition polygeneic
diseases cannot truly be modeled by the manipulation of a single
gene.
An alternative to knockout or transgenic animals is the
generation of hosts suitable for accepting xenogeneic transplants,
e.g., cells or organs. In 1983, Bosma et al described the autosomal
recessive scid mutation resulting in the inability to genetically
rearrange the receptors of the speci®c immune system, namely the
immunoglobulins and the T cell receptors (Bosma et al, 1983).
These SCID-mice lacking functional B and T cells are suitable
recipients for xenografts. Consequently, SCID-hu xenotransplanta-
tion systems have been used in many ®elds of research investigating
basic principles in biology as well as complex pathomechanisms of
de®ned diseases (Boehncke, 1999).
Normal human skin grafted onto SCID mice maintains its
architecture for a long time and many structures remain to be of
human origin (Kaufmann et al, 1993; Yan et al, 1993). Application
of this model in the ®eld of psoriasis research became feasible after it
was shown that lesional as well as nonlesional skin from patients
could be transplanted and retained clearly distinct phenotypes
(Boehncke et al, 1994; Nickoloff et al, 1995).
BIOLOGIC EFFECTS OF BACTERIAL SUPERANTIGENS
IN THE SCID-HU XENOGENEIC TRANSPLANTATION
MODEL FOR PSORIASIS
To investigate whether bacterial superantigens are capable of
triggering psoriasis we grafted nonlesional skin from psoriatic
patients onto SCID mice. Subsequently, the staphylococcal super-
antigen exfoliative toxin was repetitively injected intradermally into
the grafts to mimick chronic infection with staphylococci (Fig 1).
In addition, the patients' peripheral mononuclear cells were
stimulated in vitro with the respective superantigen and subse-
quently injected intraperitoneally into the mice. This protocol
resulted in the manifestation of psoriasis in nonlesional skin from
psoriatic donors, whereas no changes in the appearance of the grafts
was noted in skin from healthy donors (Boehncke et al, 1996).
These observations ± namely the dependency of this effect from the
presence of immunocytes preactivated by cytokines and staphylo-
coccal superantigens ± were con®rmed by Wrone-Smith and
Nickoloff (1996).
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Regarding the biologic effects of bacterial superantigens two
scenarios are possible. The effects seen could either be intrinsic
properties of the respective superantigens, or they could depend on
the environment. The former point of view is supported by
evidence for the involvement of staphylococcal superantigens in the
pathogenesis of atopic dermatitis (Leung, 1997), whereas strepto-
coccal superantigens are thought to be more relevant for the
pathogenesis of psoriasis (Leung et al, 1993). Whether this
association is indeed so strict is still a matter of debate, because at
least with reference to psoriasis reports on the presence of a T cell
in®ltrate primarily responsive to streptococcal superantigens (Baker
et al, 1995; Leung et al, 1995) stand beside ®ndings documenting T
cells reacting towards staphylococcal superantigens (Bour et al,
1995; Yokote et al, 1995). On the other hand, lack of induction of
in¯ammatory alterations by superantigens in the SCID-hu model
using grafts derived from normal human skin argues in favor of the
relevance of factors intrinsic to the skin.
We therefore analyzed the biologic effects of several super-
antigens representing distinct staphylococcal enterotoxin subfami-
lies in the SCID-hu model and were able to demonstrate
differences with regard to their respective ``psoriatrogenic'' ef®cacy,
although they all caused changes that resembled each other
(Boehncke et al, 2001). Based on these observations we think
that a predisposition intrinsic to the skin compartment is needed in
order to induce psoriasis in nonlesional skin. On the other hand the
``psoriatrogenic'' ef®cacy of distinct superantigens differs markedly.
PERSPECTIVES
Having established the inducability of psoriasis in the SCID-hu
model by superantigens we investigated the possibility of interfering
with this trigger mechanism. For this purpose, a set of mutated
superantigens with reduced af®nity to HLA class II molecules but
unaltered binding sites to T cell receptor Vb-segments were
synthetized. Preliminary data suggest that these molecules indeed
function as competitive inhibitors to the respective wild-type
superantigens in this model (Table I) (Boehncke et al, 2001). As
comparable proteins are already clinically applied in the ®eld of
oncology (Hansson et al, 1997) and the SCID-hu model has also
been demonstrated to be a useful tool for screening antipsoriatic
drugs (Boehncke et al, 1999; Dam et al, 1999), the development of
this approach for treating autoimmune diseases might well be
feasible.
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Table I. Biologic effects of wild-type and mutated
staphylococcal enterotoxin A on human nonlesional
psoriatic skin grafted onto SCID mice
Staphylococcal
superantigen A Akanthosis
Papilloma-
tosis Keratinization In®ltrate
wild type 50%±100%
thickening
++ parakeratosis intermediate
m23a ± ± orthokeratosis sparse
m23 + wild type <50%
thickening
± orthokeratosis moderate
aThis mutation exhibits no measurable af®nity to HLA class II molecules.
Figure 1. Following transplantation onto SCID mice psoriasis
can be triggered in human grafts from nonlesional skin by
repetitive intradermal injections of bacterial superantigens along
with intraperitoneal injections of activated immunocytes.
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